Last reviewed · How we verify
low dose combination of MMF and Tac
low dose combination of MMF and Tac is a Small molecule drug developed by Tuen Mun Hospital. It is currently FDA-approved. Also known as: Cellcept and Prograf.
At a glance
| Generic name | low dose combination of MMF and Tac |
|---|---|
| Also known as | Cellcept and Prograf |
| Sponsor | Tuen Mun Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose Prednisolone (PHASE2, PHASE3)
- Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation (NA)
- Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis (PHASE4)
- MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- low dose combination of MMF and Tac CI brief — competitive landscape report
- low dose combination of MMF and Tac updates RSS · CI watch RSS
- Tuen Mun Hospital portfolio CI
Frequently asked questions about low dose combination of MMF and Tac
What is low dose combination of MMF and Tac?
low dose combination of MMF and Tac is a Small molecule drug developed by Tuen Mun Hospital.
Who makes low dose combination of MMF and Tac?
low dose combination of MMF and Tac is developed and marketed by Tuen Mun Hospital (see full Tuen Mun Hospital pipeline at /company/tuen-mun-hospital).
Is low dose combination of MMF and Tac also known as anything else?
low dose combination of MMF and Tac is also known as Cellcept and Prograf.
What development phase is low dose combination of MMF and Tac in?
low dose combination of MMF and Tac is FDA-approved (marketed).
Related
- Manufacturer: Tuen Mun Hospital — full pipeline
- Also known as: Cellcept and Prograf
- Compare: low dose combination of MMF and Tac vs similar drugs
- Pricing: low dose combination of MMF and Tac cost, discount & access